Immunotherapy drugs are commonplace in mesothelioma clinical trials. However, in many cases, these drugs can’t fight cancer alone. A new Phase 2 pleural mesothelioma clinical trial is giving immunotherapy some help. Researchers from multiple cancer centers are pairing Nivolumab and Ramucirumab....
Read More
The residents of Libby, Montana, woke up each day for decades facing an environmental risk. The city was home to a vermiculite mine, which operated for much of the 20th century,...
Read PostYou’re a mesothelioma patient. You just received your diagnosis. Now you’re trying to understand the disease you have. How much do you know about it? Can you recite the names...
Read PostMay 23, 2019, is one of the most noteworthy dates in the history of mesothelioma. On that date, the U.S. Food and Drug Administration (FDA) approved a new treatment for pleural...
Read PostThe Phase 3 clinical trial for pleural mesothelioma is now looking for participants. The study is testing the effectiveness of gene therapy, immunotherapy and virotherapy...
Read Post
No two patients have the exact same mesothelioma. That’s an often-used line when specialists talk about treating the disease. If each person’s mesothelioma is unique, then...
Read Post
In the latter half of the 20th century, the general public learned of asbestos’ dangers. They learned the substance is, in fact, a carcinogen, one which can lead to aggressive...
Read Post
There are many types of immunotherapy drugs for treating mesothelioma. Some enhance the body’s immune system so it can more effectively fight diseases. Others prevent the...
Read Post
Cytoreductive surgery is the top surgical option for peritoneal mesothelioma patients. Combining it with heated intraperitoneal chemotherapy (HIPEC) has prolonged many American...
Read Post
Mesothelioma Guide is dedicated to supporting mesothelioma patients and their families. Our website is a vast resource for people looking to find treatment, financial assistance,...
Read Post
